Literature DB >> 12368782

The efficacy of continuous bupivacaine infiltration following anterior cruciate ligament reconstruction.

Heinz R Hoenecke1, Pamela A Pulido, Beverly A Morris, Jan Fronek.   

Abstract

PURPOSE: The purpose of this study was to determine whether continuous infiltration of a local anesthetic into the surgical wound for 48 hours will diminish the need for narcotics and improve the postoperative pain experience for patients undergoing anterior cruciate ligament (ACL) reconstruction using a patellar tendon autograft. TYPE OF STUDY: Prospective, randomized, double-blind study with a placebo and an experimental group.
METHODS: Twenty-six patients were randomly assigned to receive either normal saline (placebo) or bupivacaine (experimental) for 48 hours. Both groups received a single intra-articular bolus injection of 35 mL of 0.25% bupivacaine and 5 mg. of morphine at the conclusion of surgery. The placebo group received an infusion of 2 mL/h of normal saline and the experimental group received an infusion of 2 mL/h of 0.25% bupivacaine, both for 48 hours. The anesthetic was infused using a disposable elastomeric pump (Baxter Healthcare, Deerfield, IL). Patients were evaluated using a pain and pain relief assessment questionnaire and visual analogue scale (VAS). Narcotic consumption was also documented. The pump was discontinued either by the patient at home or by a physical therapist.
RESULTS: There was a statistically significant (P <.05) difference in VAS pain and pain relief scores reported by patients receiving the infusion of 0.25% bupivacaine. Patients in the treatment group also consumed 37% less narcotics than the placebo group. The operating room time, tourniquet time, weight, and age of this population were similar in the 2 groups. There were no complications with the catheter technique.
CONCLUSION: This report of a new technique suggests that surgical knee patients receiving local anesthetic infusion postoperatively experience less pain and require less narcotics. The disposable pump allowed administration of the medication on an outpatient basis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368782     DOI: 10.1053/jars.2002.36139

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  4 in total

1.  Continuous intraarticular and periarticular levobupivacaine for management of pain relief after total knee arthroplasty: A prospective randomized, double-blind pilot study.

Authors:  A Di Francesco; S Flamini; R Pizzoferrato; P Fusco; A Paglia
Journal:  J Orthop       Date:  2016-03-25

2.  Intra-synovial ropivacaine and morphine for pain relief after total knee arthroplasty: a prospective, randomized, double blind study.

Authors:  Chang-Dong Han; Doo-Hyung Lee; Ick Hwan Yang
Journal:  Yonsei Med J       Date:  2007-04-30       Impact factor: 2.759

3.  A randomized trial of bupivicaine pain pumps to eliminate the need for patient controlled analgesia pumps in primary laparoscopic Roux-en-Y gastric bypass.

Authors:  Daniel R Cottam; Barry Fisher; James Atkinson; Daniel Link; Peter Volk; Clifford Friesen; Daniel Link; Brian Grace; Robin Trovar
Journal:  Obes Surg       Date:  2007-05       Impact factor: 4.129

4.  Effectiveness of wound infusion of 0.2% ropivacaine by patient control analgesia pump after minithoracotomy aortic valve replacement: a randomized, double-blind, placebo-controlled trial.

Authors:  Gordan Mijovski; Matej Podbregar; Juš Kšela; Matej Jenko; Maja Šoštarič
Journal:  BMC Anesthesiol       Date:  2020-07-18       Impact factor: 2.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.